A novel acute kidney injury scoring system for renal and clinical outcomes in pediatric heart transplant patients

Abstract

AbstractBackgroundThe development of acute kidney injury (AKI) has been associated with worse outcomes in children after heart transplantation. Our study compares the application of a cumulative six‐point Kidney Diseases Improving Global Outcomes (KDIGO) AKI scoring system, utilizing both creatinine and urine output criteria that we term as the AKI‐6 criteria, to traditional AKI staging as a predictor for clinical and renal outcomes in the pediatric heart transplant recipients.MethodsWe conducted a retrospective single‐center chart review on 155 pediatric patients who underwent heart transplantation from May 2014 to December 2021. The primary independent variable was the presence of severe AKI. Severe AKI by KDIGO was defined as Stage ≥2, whereas severe AKI by AKI‐6 was defined as cumulative scores ≥4 or Stage 3 AKI based on either KDIGO criterion alone. Primary outcomes included actuarial survival and renal dysfunction by 1‐year post‐transplant, defined as an estimated glomerular filtration rate <60 mL/min/1.73 m2.ResultsIn total, 140 (90%) patients developed AKI; 98 (63%) patients developed severe AKI by KDIGO, and 60 (39%) by AKI‐6. Severe AKI by AKI‐6 was associated with worse actuarial survival following heart transplantation compared with KDIGO (p = 0.01). Of the 143 patients with 1‐year creatinine data, 6 (11%) patients out of 54 with severe AKI by AKI‐6 had evidence of renal dysfunction (p = 0.01), compared with 6 (7%) patients out of 88 by KDIGO (p = 0.3).ConclusionsAKI‐6 scoring provides greater prognostic utility for actuarial survival and renal dysfunction by 1‐year post‐heart transplantation in pediatric patients than traditional KDIGO staging.